| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/23/2006 | US20060062775 Method for the production of protamine |
| 03/23/2006 | US20060062772 Polypeptide delivery system |
| 03/23/2006 | US20060062761 Modified interferon alpha with reduced immunogenicity |
| 03/23/2006 | US20060062727 Compositions and methods for the diagnosis and treatment of tumor |
| 03/23/2006 | CA2580662A1 Arf-bp1 as mediator of p53-dependent and independent tumor suppression and uses thereof |
| 03/23/2006 | CA2579368A1 Sialyltransferases comprising conserved sequence motifs |
| 03/23/2006 | CA2575353A1 Cloning and expression of recombinant adhesive protein mefp-2 of the blue mussel, mytilus edulis |
| 03/22/2006 | EP1637604A2 Method for producing proteins |
| 03/22/2006 | EP1637602A1 Recombinant method for preparing of a complete malaria antigen gp190/msp1 |
| 03/22/2006 | EP1637600A1 Chromosome 1 gene and gene products related to Alzheimer's disease |
| 03/22/2006 | EP1637598A1 Cd47 partal peptdie and anti-shps-1 monoclonal antibody |
| 03/22/2006 | EP1637591A1 Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survivial of transplanted hematopoietic stem cell, human monoclonal antibody or human polyclonal antibody and method of producing the same, gene encoding human monoc |
| 03/22/2006 | EP1636360A1 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
| 03/22/2006 | EP1636340A2 Unnatural reactive amino acid genetic code additions |
| 03/22/2006 | EP1636334A2 Recombinant anti-cd30 antibodies and uses thereof |
| 03/22/2006 | EP1636268A2 Humanized antibodies that recognize beta amyloid peptide |
| 03/22/2006 | EP1636255A1 Modified oleosins |
| 03/22/2006 | EP1636248A2 Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof |
| 03/22/2006 | EP1497415A4 Cytokine receptor |
| 03/22/2006 | EP1246909B1 Method for the production of hydroxynitrile lyases |
| 03/22/2006 | EP1008603B1 Soluble polypeptides consisting on the first coiled coil domain of human and mouse epimorphin. |
| 03/22/2006 | EP0914456B1 Gene expression in monocytes and macrophages |
| 03/22/2006 | EP0864645B9 Negative-strand rna virus vector having autonomously replicating activity |
| 03/22/2006 | EP0799318B1 Methods of modifying carbohydrate moieties |
| 03/22/2006 | CN1749404A I-type protein small peptide and its preparing method |
| 03/22/2006 | CN1749275A Method for processing hydrolytic fish skin collagen |
| 03/22/2006 | CN1749271A Human new protein Hunsp 18 and its code sequence |
| 03/22/2006 | CN1246473C Process for biological enzyme extraction of grape seed polypeptide protein |
| 03/22/2006 | CN1246459C Human composite alpha-interferon engineered gene, its expression and production thereof |
| 03/22/2006 | CN1246458C Human cervical cancer 2 protooncogene and protein encoded therein |
| 03/22/2006 | CN1246337C Novel TNFR-Fc fusion protein |
| 03/22/2006 | CN1246335C Recombinant IL-18 antagonist useful in treatment of IL-18 mediated disorders |
| 03/22/2006 | CN1246334C Antibodies capable of detecting beer spoilage lactic acid bacteria and detecting method using same, and reagent kit with same |
| 03/22/2006 | CN1246333C Receptor in the EDb Fibronection domain |
| 03/22/2006 | CN1245894C Cultured protein hydrolytic product |
| 03/22/2006 | CA2482380A1 Beta-parvin expression for use in diagnostic methods for assessment of breast cancer |
| 03/21/2006 | US7015311 That binds to a neurturin polypeptide of given sequences that promotes survival of superior cervical ganglion cells or nodose ganglion cells; can be used to detect and monitor patient levels of neurturin |
| 03/21/2006 | US7015308 human Desert hedgehog protein of given sequence; a drug target: efficacy in elucidation of hereditary morphological abnormalities in humans to establish their treatments and diagnoses |
| 03/21/2006 | US7015023 A hormone binding domain linked to a beta -glucuronidase enzyme by a peptide containing a caspase cleavage site (beta -glucuronidase is inactive due to linkage to the hormone binding domain), release of the beta -glucuronidase through caspase split |
| 03/21/2006 | US7015016 Use of protein derived from cancer cells, cells infected by a virus or immune cells or an inactive fragment thereof, protein being initially an immunosuppressive and/or angiogenic protein for obtaining medicines to provide mucosal immunity |
| 03/21/2006 | US7015015 Nucleotide sequences coding polypeptide for use in treatment of diabetes, epilepsy, depression, ischemia and muscle disorders |
| 03/21/2006 | US7015008 Comprises inhibitory monoclonal antibody for controlling metabolic processes associated with cytochrome c oxidase/debrisoquine hydroxylase; drug screening and development; competetive binding |
| 03/21/2006 | US7015007 Contacting a sample with an isolated monoclonal antibody that binds to a substantially-pure coagulase-negative Staphylococcus epidermidis capsular polyssocharide adhesin antigen that binds to polymeric material, wherein said adhesin antigen inhibits binding to polymeric material |
| 03/21/2006 | US7015004 Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance |
| 03/21/2006 | US7014853 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 03/21/2006 | CA2154080C Novel anticoagulant cofactor activity |
| 03/21/2006 | CA1341502C Method for the production of erythropoietin |
| 03/16/2006 | WO2006029389A2 Tryptophan-processing enzymes, nucleic acids encoding them and methods for making and using them |
| 03/16/2006 | WO2006028655A2 Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer |
| 03/16/2006 | WO2006028197A1 Anti-a33 antibody |
| 03/16/2006 | WO2006026992A1 Altered structure of n-glycans in a fungus |
| 03/16/2006 | WO2005070468A3 Transglutaminase mediated conjugation of peptides |
| 03/16/2006 | WO2005021723A3 Nucleic acid molecules from rice controlling abiotic stress tolerance |
| 03/16/2006 | US20060059575 Method for preparing monoclonal antibody |
| 03/16/2006 | US20060058520 Detecting activity of a Silent information regulator 2 by combining the composition with adenosine 5'-diphosphate and an acetylated Sir2 peptide substrate to deacetylate the peptide, and identifying 2'/3'-O-acetyl-ADP-ribose in the mixture to determine the presence of Sir2 activity |
| 03/16/2006 | US20060058512 Process for producing humanized chimera antibody |
| 03/16/2006 | US20060058509 Refolding of membrane proteins |
| 03/16/2006 | US20060058507 Krib polynucleotides and polypeptides and uses thereof in the treatment of metabolic disorders |
| 03/16/2006 | US20060058505 Nucleic acid and polypeptide linked to breast cancer and uses therefor |
| 03/16/2006 | US20060058234 VEGF traps and therapeutic uses thereof |
| 03/16/2006 | US20060057700 Using glycosylated pilin as diagnostic indicator and preventative initation in treating pseudomonal infections; immunotherapy; glycosylated with the O-antigen; Pseudomonas aeruginosa; Escherichia coli |
| 03/16/2006 | US20060057698 Nucleic acids and polypeptides involved in the production of cryptophycin |
| 03/16/2006 | US20060057697 Transfers a D-glucuronic acid residue to an N-acetyl-D-galactosamine residue when the N-acetyl-D-galactosamine residue is present at the non-reducing end of the chondroitin backbone, or transfers an N-acetyl-D-galactosamine residue to a D-glucuronic acid residue |
| 03/16/2006 | US20060057696 Sugar chain synthases |
| 03/16/2006 | US20060057695 GANP protein |
| 03/16/2006 | US20060057694 Rat receptor tyrosine knase, kdr |
| 03/16/2006 | US20060057680 Mutant interleukin-15 polypeptides |
| 03/16/2006 | US20060057679 RAGE protein derivatives |
| 03/16/2006 | US20060057678 Chimeric proteins for diagnosis and treatment of diabetes |
| 03/16/2006 | US20060057677 Organic anion transporter and gene coding for the same |
| 03/16/2006 | US20060057676 which are induced by fermentable glucose or non-fermentable ethanol |
| 03/16/2006 | US20060057675 Human toll homologue |
| 03/16/2006 | US20060057674 Translocating enzyme as a selection marker |
| 03/16/2006 | US20060057673 Epitope analogs |
| 03/16/2006 | US20060057672 Exo-endo cellulase fusion protein |
| 03/16/2006 | US20060057671 Immobilized probes and methods of detecting conformationally altered prion proteins |
| 03/16/2006 | US20060057670 Genomic markers of hepatitis B virus associated with hepatocellular carcinomas |
| 03/16/2006 | US20060057669 Inactive transcription factor tif-ia and uses thereof |
| 03/16/2006 | US20060057668 Antimicrobial polypeptide and utilization thereof |
| 03/16/2006 | US20060057667 Provides isolated peptide and nucleic acid molecules, methods of identifying orthologs and paralogs of the transporter peptides, and methods of identifying modulators of the transporter peptides |
| 03/16/2006 | US20060057666 Human g protein coupled receptor |
| 03/16/2006 | US20060057665 Galectin-14 therapeutic molecule and uses thereof |
| 03/16/2006 | US20060057664 Polypeptides and polynucleotides encoding same |
| 03/16/2006 | US20060057663 Novel g protein-coupled receptor protein and dna thereof |
| 03/16/2006 | US20060057662 Membrane scaffold proteins |
| 03/16/2006 | US20060057660 Method for measuring protein NMR |
| 03/16/2006 | US20060057641 Having T cell stimulatory activity of a dog dander allergen, therapy |
| 03/16/2006 | US20060057612 Methods for diagnosing osteoporosis or a susceptibility to osteoporosis based on haplotype association |
| 03/16/2006 | US20060057602 related to testes-specific, vespid and pathogenic proteins (RTVP); metastatic prostatic neoplasia |
| 03/16/2006 | US20060057601 Genomic markers of hepatitis B virus associated with hepatocellular carcinoma |
| 03/16/2006 | US20060057600 Methods for detecting DNA viruses |
| 03/16/2006 | US20060057146 Selective targeting of tumor vasculature using antibody molecules |
| 03/16/2006 | US20060057141 Ovarian carcinoma polypeptides having a specific amino acid sequence, its fusion proteins and polynucleotides encoding them; cancer vaccines |
| 03/16/2006 | US20060057139 Process for producing humanized chimera antibody |
| 03/16/2006 | US20060057135 Mucosal vascular addressins and uses thereof |
| 03/16/2006 | US20060057131 Malleable protein matrix and uses thereof |
| 03/16/2006 | US20060057115 Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof |
| 03/16/2006 | US20060057112 Macrophage derived chemokine (MDC), MDC analogs, MDC inhibitor substances and uses thereof |
| 03/16/2006 | US20060057072 Method for diagnosis and treatment of vascular disease |
| 03/16/2006 | DE19943383B4 Regulatorische Sequenzen und Expressionskassetten für Hefen Regulatory sequences and expression cassettes for yeasts |